LIXT - Lixte Biotechnology Holdings, Inc. Stock Price, Fair Value and News

LIXT is the stock ticker symbol of Lixte Biotechnology Holdings, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Lixte Biotechnology Holdings, Inc. is 21.28 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check LIXT's fair value in chart for subscribers.

The fair value guage provides a quick view whether LIXT is over valued or under valued. Whether Lixte Biotechnology Holdings, Inc. is cheap or expensive depends on the assumptions which impact Lixte Biotechnology Holdings, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LIXT.

As of Wed Jan 28 2026, LIXT's PE ratio (Price to Earnings) is -5.21 and Price to Sales (PS) ratio is 138.04. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LIXT PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Lixte Biotechnology Holdings, Inc. has provided -0.123 (multiply by 100 for percentage) rate of return.